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S U M M A R Y
Objective: The aim of this study was to describe an outbreak of Burkholderia stabilis colonization among
patients in a nasal ward.
Methods: Multilocus sequence typing (MLST) was used for the molecular typing of B. stabilis isolates.
Microbiological records were reviewed to delineate the colonization outbreak period. One hundred
seventy-one cultures of environment and equipment samples from the nasal ward were performed to
trace the source of contamination. Infection control measures were taken in order to end the outbreak.
Results: All B. stabilis isolates were identiﬁed as a new MLST type, ST821. A total of 53 patients carried
this B. stabilis in the nasal ward between March and September 2013, which was deﬁned as the outbreak
period. The source of the colonization was not determined because all environment cultures were
negative for Burkholderia cepacia complex. No further B. stabilis carriers have been found in the ward
since the implementation of interventions.
Conclusions: Attention must be paid to asymptomatic colonization in order to identify outbreaks early.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The Burkholderia cepacia complex (Bcc) comprises at least
17 distinct species, including Burkholderia stabilis, Burkholderia
cepacia, Burkholderia cenocepacia, and Burkholderia multivorans,
which are widely distributed in the natural environment, such as
soil, water, and the rhizosphere.
Bcc species are particularly virulent, devastating pathogens for
individuals suffering from cystic ﬁbrosis (CF)1,2 or chronic
granulomatous disease, but are also important opportunistic
pathogens that can cause nosocomial infections.3,4 So far, many
genomovars have been isolated from hospital outbreaks. Medina-
Pascual et al. reported that B. cenocepacia was the most prevalent
genomovar found in patients with CF, whereas B. cepacia was the
most common among non-CF patients. B. stabilis was the most
common environmental genomovar.5 Furthermore, reported out-
breaks of Bcc species infections have been linked to the
contamination of medical devices, disinfectants, and medical
solutions.4,6* Corresponding author. Tel.: +86-010-56119227.
E-mail address: wanglijun@btch.edu.cn (L. Wang).
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1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/4.0/).Various epidemiological typing methods are currently utilized
for infection outbreak investigations, such as multilocus restriction
typing,7 pulsed-ﬁeld gel electrophoresis (PFGE), and random
ampliﬁed polymorphic DNA (RAPD). PFGE is used widely, but is
not a transferable technique. The multilocus sequence typing
(MLST) method is a means to assist in species identiﬁcation as well
as unambiguous strain discrimination of the Bcc, and can facilitate
global epidemiological investigations of Bcc.8,9
In the present study, we describe a 7-month outbreak of
B. stabilis colonization among hospitalized patients with nasal
disease. An environmental investigation was implemented to trace
the source of the colonization, and infection control measures were
implemented to terminate the outbreak. To our knowledge, this is
the ﬁrst report of an outbreak of B. stabilis colonization from a nasal
ward in China.
2. Materials and methods
2.1. Clinical characteristics
This study took place in a 500-bed tertiary hospital in Beijing,
China, ophthalmology and otolaryngology. The colonizationciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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14 rooms.
Samples were obtained from the middle meatus under nasal
endoscopic guidance from all patients on the day subsequent to
admission to the ward and were submitted to culture and
pathogen diagnosis. Almost all patients underwent an endoscopic
sinusotomy as part of the therapeutic management.
All microbiological records of the hospital laboratory informa-
tion system were reviewed to establish the colonization outbreak
period. ‘Colonization’ was deﬁned as B. stabilis isolated from any
body site without any apparent infection. ‘Outbreak’ was deﬁned
as the simultaneous presence of two patients with positive
cultures for B. stabilis.
2.2. Microbiological studies
Clinical swabs were cultured on Columbia agar plates
supplemented with 5% sheep blood and incubated at 37 8C for
24–48 h. The initial identiﬁcation was done using a matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry
assay (MALDI-TOF MS). Environmental sample swabs were
cultured in trypticase soy broth, and then subcultured after 24 h
and processed as above. Disinfectants and water were cultured on
Columbia agar plates supplemented with 5% sheep blood.
The MALDI-TOF MS assay was performed using a MALDI-TOF
Autoﬂex III (Bruker Daltonics) operating in linear positive ion
mode at a laser frequency of 200 Hz in a mass range of 2–20 kDa.
Spectra were analyzed using MALDI Biotyper software (Bruker
Daltonics) and using the Biotyper Library (Bruker Daltonics)
for database searching and identiﬁcation.10,11 recA sequenc-
ing and MLST were performed at the species-level for Bcc
isolates.12
Minimum inhibitory concentration (MIC) results for trimetho-
prim–sulfamethoxazole, ceftazidime, meropenem, and levoﬂox-
acin were determined by Vitek 2 system (bioMe´rieux Inc., Durham,
NC, USA). The results were interpreted according to the criteria of
the Clinical and Laboratory Standards Institute (CLSI) for Bcc
species. The control strains used were Pseudomonas aeruginosa
ATCC 27853 and Escherichia coli ATCC 25922.
2.3. Multilocus sequence typing (MLST)
MLST of the isolates was done using seven standard house-
keeping genes (atpD, gltB, gyrB, lepA, phaC, trpB, recA) according to
the protocol and primers speciﬁed in a public database of MLST
sequence data (http://pubmlst.org/bcc/).8 DNA sequencing was
performed commercially by SinoGenoMax Co. Ltd (Beijing, China).
Clustering analysis of the MLST association with proﬁles identiﬁed
worldwide was performed using BURST software (http://eburst.
mlst.net/v3).
2.4. Environmental screening
As well as the middle meatus specimen cultures obtained under
nasal endoscopic guidance, surveillance cultures were also done in
association with endoscope-related procedures. On the ward, nasal
endoscopes were disinfected in stages, in accordance with the
manufacturer’s recommendations, including cleaning, disinfecting
in sodium dichloroisocyanurate–synergist HZ704 solution for
5 min, and rinsing.
Epidemiological environmental sampling was carried out in
every ward room and examination room by swab-rinse sampling
method, including tabletops (n = 48), bed rails (n = 45), knobs
(n = 48), taps (n = 11), hand lotion (n = 3), nasal endoscope (n = 6),
and physician’s hands (n = 4). All disinfectants (n = 6) used in the
ward were also subjected to culture.2.5. Infection control measures
General interventions used to control the spread of multidrug-
resistant organisms include hand hygiene measures and environ-
mental cleaning.13 Bcc nosocomial outbreaks are typically
associated with water and medical products.14,15 Therefore, the
nurses began to implement the following infection control
measures on September 15, 2013. First, environmental surfaces,
taps, and medical devices were disinfected with 75% alcohol.
Second, the nasal endoscope disinfection time was extended
to 10 min with the use of a high-level disinfectant, sodium
dichloroisocyanurate–synergist HZ704. Third, healthcare hand
hygiene was strengthened in the ward.
3. Results
3.1. Epidemiological features
After reviewing the medical records, the ﬁrst appearance of B.
stabilis in the ward occurred on March 19. From March to
September 2013, a total of 740 patients suffering from chronic
bacterial or fungal sinusitis were admitted to the ward and had
microbiological cultures done on admission. Fifty-eight sample
cultures from 53 patients, including ﬁve nasal pyogenic excretions
obtained surgically during operations and 53 middle meatus
swabs, were positive for B. stabilis between March and September
2013. None of the patients developed B. stabilis infections.
Colonization was deﬁned as Bcc isolation from any body site
without any apparent infection; in this way the outbreak of B.
stabilis colonization was identiﬁed. The colonized patients were
distributed across every ward room. The outbreak period was
deﬁned as the time between March 19 and September 20,
2013. The pre-outbreak period was deﬁned as June 2012 through
February 2013. The post-outbreak period was deﬁned as October
2013 through March 2014. The peak colonization occurred in July
and August (Figure 1). The last isolate of B. stabilis was obtained on
September 20. No cultures were positive for B. stabilis during the
pre-outbreak and post-outbreak periods in the nasal ward.
Two isolates of B. multivorans were isolated from a patient in the
intensive care unit (ICU) in December 2012 – one from sputum and
the other from hydrothorax.
None of the environment cultures, including disinfectants,
surfaces, and equipment, grew B. stabilis. The source of the
colonization was not determined.
3.2. Isolate features
All clinical isolates were identiﬁed as B. stabilis by recA gene.
Two isolates were resistant to meropenem and three isolates were
resistant to ceftazidime. Other isolates were susceptible to
meropenem, ceftazidime, trimethoprim–sulfamethoxazole, and
levoﬂoxacin.
3.3. MLST
Epidemiological typing of all B. stabilis isolates showed them to
be identical, belonging to sequence type ST821, which was
uploaded to the database (http://pubmlst.org/bcc/). ST821 is a
new type and has no correlation with any other proﬁle worldwide
(Figure 2).
3.4. Infection control
After control measures were implemented in September 2013,
B. stabilis colonization declined. So far as we know, no further
clinical cultures in the nasal ward have grown B. stabilis. The
Figure 1. Epidemic curve showing the number of cases of colonization with
Burkholderia stabilis in the nasal ward from June 2012 to March 2014. The line
indicates colonized patients.
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there was zero colonization in October and November (Figure 1).
4. Discussion
We have described a 7-month outbreak of B. stabilis coloniza-
tion among hospitalized nasal disease patients. During the
outbreak, B. stabilis species were isolated from 53 patients with
sinusitis. During attempts to establish an etiological diagnosis for
the sinusitis, swabs of material draining from the middle meatus
were obtained under endoscopic guidance and were cultured.Figure 2. BURST analysis showing the relationship between ST821 and another
861 MLST proﬁles in the database (http://pubmlst.org/bcc/). The eBURST diagram
showed the primary founder assigned by eBURST (blue circle) and was then re-
drawn with ST821 as the primary founder (red circle). Each sequence type that has
at least two descendent single-locus variants (SLVs) (a total of three including the
SLV that is its progenitor) will under the default deﬁnition be assigned as a
subgroup founder and colored yellow. ST821 has zero SLV and zero double-locus
variants (DLV), indicating a signiﬁcant phylogenetic divergence.B. stabilis is not the main etiological pathogen in such patients
and the patients had no symptoms of B. stabilis infection, hence the
physicians and clinical microbiology technologists initially paid no
attention to the fact that a cluster of cultures were positive for B.
stabilis among middle meatus drainage specimens. Only when
several colonized cases were detected in July and August did the
clinical microbiology technologists take note of this unusual
phenomenon; they then analyzed the phylogenetic relationship
between the isolates. All strains showed an identical MLST pattern,
ST821, which is a new type with no correlation with any other
proﬁle worldwide. The infection control committee then triggered
an investigation in September 2013.
Eliminating the source of an outbreak is of importance to
prevent additional cases. We analyzed the possible sources in
order to implement infection control measures. First, environ-
mental surfaces, which may serve as reservoirs for transmission,
were preferred in the epidemiological survey. Second, Bcc species
are widespread in the environment and are able to colonize diverse
niches. It is widely accepted that the natural environment is a
potential source of infectious Bcc.3 This has been demonstrated in
numerous studies involving infections or outbreaks related to tap
or sink drain contamination by non-fermenting Gram-negative
bacteria.16,17 Third, inadequate preparation of chlorhexidine
solutions diluted with contaminated puriﬁed water may have
resulted in an outbreak of B. cenocepacia.6 Products commonly
used in the nasal ward may have been involved in these outbreaks.
Fourth, hospitalized patients in the ward were subjected to nasal
endoscopic examination, so contamination with Bcc bacteria may
also have occurred from the nasal endoscope and related
equipment. Given that Bcc bacteria possess very high resistance
to biocides, all solutions used in equipment disinfection proce-
dures were cultured.18 Lastly, in order to exclude clinician-to-
patient transmission, the hands of clinicians were also cultured.
Considering the epidemiology of Bcc and the factors above, we
cultured samples of disinfectants, equipment, and environmental
surfaces. At the same time, all microbiological records of the
hospital laboratory information system from recent years were
reviewed and it was found that two isolates of B. multivorans were
isolated from sputum and hydrothorax of a patient in the ICU in
December 2012. However, no other species of Bcc were isolated in
the hospital between the years 2012 to 2013. It is unlikely that the
B. stabilis was transmitted from other wards. However, none of the
171 epidemiological investigation sample cultures grew B.
stabilis. No colonization source was identiﬁed. We had to
implement infection control measures according to historical
studies and experiences. On September 15, 2013, the nurses began
to implement environmental screening and infection control
measures. After the intervention strategies, the B. stabilis outbreak
was terminated.
According to a review written by Gastmeier et al., the source is
not found in 37% of outbreaks.19 Identiﬁcation of the outbreak
source and its control represents a challenge. In our study,
disinfection of the environment and endoscope was very effective
in reducing the incidence of colonization even though the source
remained unknown.
Only a few studies have reported B. stabilis as the cause of
nosocomial infection.20,21 A possible explanation for the asymp-
tomatic colonization outbreak is that most cases in the nasal ward
were relatively mild and unsusceptible to B. stabilis. In our study,
two isolates were resistant to meropenem and three isolates were
resistant to ceftazidime; this resistance of B. stabilis is unusual.
Once infected, treatment may be more difﬁcult.
In most circumstances, the clinical microbiology technicians
report the main etiological pathogen in the various samples,
however they neglect the opportunistic pathogens. In our study,
a cluster of B. stabilis in swabs indicated an outbreak. Although the
L. Wang et al. / International Journal of Infectious Diseases 33 (2015) 71–7474B. stabilis was reported by the clinical microbiology technicians in
our hospital, the physician and infection control committee failed
to highlight the asymptomatic colonization causing an outbreak.
In conclusion, two main lessons were learned from this 7-
month outbreak of B. stabilis colonization. First, opportunistic
pathogens found in clinical samples should be reported by the
clinical microbiology department and noted by health workers.
Second, it is of importance to pay attention to asymptomatic
colonization to avoid outbreaks.
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